The Morpheus8 Body applies the tried-and-true method of microneedling
A potent and selective 11-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice models
Because symptoms of B12 deficiency can overlap with many other conditions, self-diagnosis is not ideal
Little or no tumor specificity, poor tumor penetration, cancer cell heterogeneity, insufficient drug accumulation into the tumors abound with the development of multidrug resistance (MDR) conferred by many factors, and finally, undesirable side effects are all crucial matters that contribute to the lack of effectiveness and eventually therapeutic failure observed in conventional cancer therapeutics
Weight loss drugs benefit from a clear, measurable endpoint and a clinical infrastructure already oriented toward chronic metabolic disease
John Lin, C